Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5462961 | 0.84 | HDAC1 (0.41) | TBXAS1ALDH1A1LMNAGLAHPGD | |
| SCHEMBL10118094 | 0.83 | ALDH1A1 (0.54) | TBXAS1ALDH1A1LMNAKDM4EPOLB | |
| SCHEMBL5449147 | 0.80 | ALDH1A1 (0.54) | ALDH1A1KDM4ENPC1GAARAB9A | |
| SCHEMBL30366356 | 0.78 | FAAH (0.44) | TBXAS1ALDH1A1LMNAKDM4ECYP3A4 | |
| SCHEMBL3536795 | 0.77 | DHODH (0.42) | TBXAS1ALDH1A1LMNADHODHCYP1A2 | |
| SCHEMBL5457550 | 0.77 | RAD51 (0.40) | ALDH1A1KDM4EHPGDNPC1RAB9A | |
| SCHEMBL7824907 | 0.75 | ALDH1A1 (0.48) | TBXAS1ALDH1A1KDM4EPOLBDHODH | |
| SCHEMBL5467914 | 0.75 | DHODH (0.41) | TBXAS1KDM4EDHODHCYP1A2CYP3A4 | |
| SCHEMBL222908 | 0.75 | NR4A1 (0.60) | ALDH1A1LMNAKDM4EGLAHPGD | |
| SCHEMBL27356901 | 0.75 | ALDH1A1 (0.55) | ALDH1A1LMNAKDM4EGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110177781-A | Bruton's tyrosine kinase inhibitor | BIOCAD股份有限公司 | 2019-08-27 | — | — | CN | disclosed |
| US-7718576-B2 | Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein | WALDROP III ALEXANDER A | 2010-05-18 | — | — | US | disclosed |
| CN-1902178-A | Therapeutic agents useful for treating pain | EURO CELTIQUE SA (LU) | 2007-01-24 | — | — | CN | disclosed |
| CN-1863790-A | Therapeutic agents useful for treating pain | EURO CELTIQUE SA (LU) | 2006-11-15 | — | — | CN | disclosed |
| CN-1856489-A | Phenyl-carboxamide compounds useful for treating pain | EURO CELTIQUE SA (LU) | 2006-11-01 | — | — | CN | disclosed |
| CN-1832935-A | Therapeutic agent for treating pain | EURO CELTIQUE SA (LU) | 2006-09-13 | — | — | CN | disclosed |
| EP-1019379-B1 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | MAINE MEDICAL CT (US) | 2005-10-19 | — | — | EP | disclosed |
| US-20030219844-A1 | Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein | MAINE MEDICAL CENTER | 2003-11-27 | — | — | US | disclosed |
| EP-1019379-A4 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | MAINE MEDICAL CT (US) | 2001-07-04 | — | — | EP | disclosed |
| EP-1019379-A1 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | Maine Medical Center (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999009012-A1 | PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN | MAINE MEDICAL CENTER (US) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030219844-A1 | Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein | CBR1, CBR3, NR2E3 | TBXAS1 1194/4885ALDH1A1 461/4885LMNA 3309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.